Electromed (ELMD) Assets Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.56% |
| Dec 31, 2025 | 9.88% |
| Sep 30, 2025 | 10.13% |
| Jun 30, 2025 | 9.16% |
| Mar 31, 2025 | 10.36% |
| Dec 31, 2024 | 11.02% |
| Sep 30, 2024 | 8.88% |
| Jun 30, 2024 | 12.07% |
| Mar 31, 2024 | 9.57% |
| Dec 31, 2023 | 9.45% |
| Sep 30, 2023 | 8.61% |
| Jun 30, 2023 | 11.28% |
| Mar 31, 2023 | 9.12% |
| Dec 31, 2022 | 9.55% |
| Sep 30, 2022 | 9.82% |
| Jun 30, 2022 | 12.05% |
| Mar 31, 2022 | 12.11% |
| Dec 31, 2021 | 12.43% |
| Sep 30, 2021 | 11.27% |
| Jun 30, 2021 | 10.65% |
| Mar 31, 2021 | 15.28% |
| Dec 31, 2020 | 14.76% |
| Sep 30, 2020 | 14.01% |
| Jun 30, 2020 | 12.97% |
| Mar 31, 2020 | 14.62% |
| Dec 31, 2019 | 15.00% |
| Sep 30, 2019 | 15.43% |
| Jun 30, 2019 | 12.63% |
| Mar 31, 2019 | 11.45% |
| Dec 31, 2018 | 12.16% |
| Sep 30, 2018 | 16.00% |
| Jun 30, 2018 | 16.32% |
| Mar 31, 2018 | 12.62% |
| Dec 31, 2017 | 12.42% |
| Sep 30, 2017 | 12.01% |
| Jun 30, 2017 | 13.45% |
| Mar 31, 2017 | 10.80% |
| Dec 31, 2016 | 5.97% |
| Sep 30, 2016 | 4.21% |
| Jun 30, 2016 | 5.44% |
| Mar 31, 2016 | 2.02% |
| Dec 31, 2015 | -0.16% |
| Sep 30, 2015 | -4.82% |
| Jun 30, 2015 | -5.95% |
| Mar 31, 2015 | -6.56% |
| Dec 31, 2014 | -6.99% |
| Sep 30, 2014 | -7.94% |
| Jun 30, 2014 | -8.87% |